From October 17th to 19th, Sinclair, a leader in global medical aesthetics, welcomed nearly a thousand clinical aesthetic physicians, industry professionals, and media representatives from around the world to the World Expert Meeting 2024 (hereinafter referred to as WEM) – Sinclair Global Medical Aesthetics Summit in the vibrant and artistic city of Barcelona.

Fira de Barcelona Exhibition Centre, Venue ofWEM 2024

With participants from 59 countries and regions, the summit served as a key platform for sharing the latest advancements and clinically valuable topics in aesthetic medicine. The focus of WEM 2024 was to provide a fresh, international perspective on clinical practices and innovations, offering attendees the opportunity to exchange knowledge, integrate global medical resources, and explore the intersection of Chinese and Western approaches to aesthetic medicine.

Building a global platform to connect and empower physicians from all over the world

WEM has established itself as one of the world’s leading forums for medical beauty professionals. It is dedicated to empowering physicians with access to the latest clinical case studies and material science innovations to provide better and more advanced beauty solutions for patients worldwide.

Amber Edwards, global CEO of Sinclair, said in her speech,"We hope to bring better facial anti-aging to patients around the world with a new perspective, cutting-edge medical beauty knowledge, top medical beauty products, and advanced science and technology. Continuous exploration and innovation. This is our responsibility and our mission."

Amber Edwards, global CEO of Sinclair, delivered an opening speech

At the WEM, global experts shared insights on over 80 topics, including facial anatomy, advanced injection techniques, combination therapies, case studies, new material applications, and emergency management of adverse reactions. The summit also featured presentations from leading global brands such as ELLANSÉ, MaiLi, Lanluma, and Reaction, offering fresh inspiration for creating more effective anti-aging treatment plans. In addition, when it comes to the digital transformation of the industry, experts discussed innovative marketing models aimed at helping practitioners better understand consumer needs and improve service delivery.

Zhang Yahang, Zhu Boyan, and Wang Yongshu, three distinguished speakers from China, delivered impactful presentations, sharing their expertise and experiences. Their contributions brought valuable Chinese perspectives to the global stage, garnering significant attention and recognition from other attendees. The increasing presence of Chinese physicians in international academic forums highlights the growing influence of Chinese aesthetic medicine. It also further solidified the significance of Sinclair and the ongoing role of WEM as a premier platform for knowledge exchange and innovation in medical aesthetics.

Zhang Yahang, Zhu Bainian and Wang Yongshu shared their experiences at WEM

Bringing China’s Voice to the Global Stage

The Asia-Pacific division played a significant role at this year’s WEM, where more than 100 aesthetic experts from China and the Asia-Pacific region shared their expertise. With a strong academic foundation and extensive clinical experience, these experts engaged in lively discussions with their global counterparts, driving technological innovation and breakthroughs in aesthetic medicine and delivering safer, more effective, and personalized treatment plans to meet the growing demands of patients.

Zhou Zhaohua, Vice President of Sinclair Asia Pacific and CEO of Sinclair China said in her speech,“We always listen to the real needs of patients. By blending Eastern aesthetic principles with a diverse product portfolio, we aim to better meet the expectations of Chinese consumers. The success of Ellansé in the Chinese market is just the beginning. We are committed to introducing more high-quality products in the future.”

Speech by Zhou Zhaohua, Vice President of Sinclair Asia Pacific and CEO of Sinclair China

At the WEM, spearheaded by Professor Luo Shengkang from GuangdongSecond Provincial General Hospital, Professor Cui Haiyan of Tongji Hospital of Tongji University, and Professor Chen Guangyu of the Plastic Surgery Hospital of the Chinese Academy of Medical Sciences, the ELLANSÉ Asia Pacific Consensus was developed in collaboration with 14 other prominent Chinese specialists. The Consensus introduces advanced guidelines for the scientific application of ELLANSÉ®’s second-generation products, Ellansé S, Ellansé M, and Ellansé L. These products are designed to meet diverse beauty needs with precision, offering refined methods to help physicians tailor treatments for their patients.

Professor Luo Shengkang,(Left), Professor Chen Guangyu (Middle), Professor Cui Haiyan (Right)

During the WEM 2024, leading experts provided in-depth interpretations of the newly established ELLANSÉ Asia Pacific Consensus. Professor Luo Shengkang said,"With the rapid progress of material science and medical aesthetics technology, the safety, biocompatibility, and therapeutic effects of facial filler materials have been thoroughly validated in both scientific research and clinical practice." Professor Chen Guangyu said,"For younger Asian patients, injection treatments aim to precisely adjust facial proportions and optimize structural features, while for older patients, it is to maintain facial stability and fullness, effectively addressing wrinkles and skin sagging caused by aging. This approach scientifically combats the visible signs of aging." Professor Cui Haiyan pointed out,"Thanks to the development of science and technology and the deepening of research, I’m pleased to see the advancements in our ability to control the particle size of PCL microspheres, which not only promotes collagen regeneration but also allows us to offer more refined, personalized anti-aging solutions based on varying levels of patient needs."

During this trip to Barcelona, Sinclair unveiled the impressive clinical case results of“Scientific Haute Couture”, the second-generation product of ELLANSÉ®. In addition to ELLANSÉ®, Sinclair shared new insights into other leading brands in its portfolio, including Reaction and Glacial Spa. Looking ahead, Sinclair is set to launch two exciting new products: MaiLi, a luxury hyaluronic acid treatment, and Renotion, a groundbreaking skin rejuvenation solution. Both products are eagerly anticipated and expected to bring fresh, cutting-edge options for patients seeking the latest in aesthetic care.

Immersive experience, one-stop anti-aging solution

At the WEM, the integration of the latest AI technology took center stage, transforming the event into an immersive anti-aging laboratory. This innovative approach allowed attendees to explore and experience the latest products and technologies in a highly interactive, scenario-based setting. This cutting-edge approach may soon lead to novel experiences and more personalized treatment methods for patients around the world.

Attendees and the product demonstratorduring the event on-site

Whether it’s medical aesthetics or daily beauty treatments, consumers are no longer solely focused on the products themselves when choosing solutions; service and experience have become equally important. Today’s patients are increasingly drawn to personalized, refined treatments and a more comfortable user experience, which greatly influence their decisions.

The 2024 WEM concluded on a high note, showcasing the growth and development of the“new anti-aging” movement. The summit highlighted the opportunities and challenges ahead in“personalized anti-aging treatments”, emphasizing the importance of tailoring solutions to individual needs. The immersive nature of this year’s event, which combined theoretical knowledge with practical applications, provided participants with invaluable insights and hands-on experience.

Group photo of attendees

Looking ahead, Sinclair is set to leverage its extensive global resources and continually optimize its product pipeline. The company’s commitment to advancing its academic influence, from clinical micro-technology breakthroughs to driving industrial development, positions Sinclair to shape the future of aesthetic medicine!